Skip to main content

Table 1 Association of Hp1γ expression with patient pathological features

From: HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy

Variable

Number

Nucleus

Cytoplasm

Total

  

Mean intensity (SD)

p-value

Mean intensity (SD)

p-value

Mean intensity (SD)

p-value

Gleason

       

 3+3 or 3+4

47

8.77 (2.5)

0.018

3.02 (0.8)

0.095

11.8 (3.2)

0.042

 4+3 or 4+4 or 4+5

12

10.74 (2.5)

 

4.1 (2.0)

 

14.9 (4.5)

 

Stage

       

 T2

40

8.62 (2.7)

0.238

2.86 (0.9)

0.039

11.48 (3.4)

0.12

 T3

12

9.46 (1.6)

 

3.47 (0.7)

 

12.92 (2.2)

 

 T4

11

10.0 (2.9)

 

3.77 (2.0)

 

13.78 (4.7)

 

Tumor Volume

       

 <5

7

9.59 (1.8)

0.776

3.07 (0.8)

0.156

12.67 (2.4)

0.879

 5-20

36

8.84 (2.9)

 

3.06 (1.4)

 

11.91 (4.0)

 

 >20

20

9.09 (2.4)

 

4.01 (2.5)

 

12.03 (3.1)

 

SV involvement

       

 No

49

8.96 (2.6)

0.684

3.04 (1.2)

0.182

12.01 (3.7)

0.468

 Yes

11

9.30 (2.5)

 

4.76 (3.0)

 

12.29 (3.3)

 

Margins Positive

       

 No

41

9.40 (2.6)

0.105

3.22 (1.3)

0.469

12.55 (3.7)

0.876

 Yes

21

8.25 (2.5)

 

3.0 (1.0)

 

11.25 (3.4)

 

Extracapsular

       

 No

46

8.91 (2.8)

0.633

3.39 (2.0)

0.875

11.83 (3.8)

0.471

 Yes

17

9.26 (2.0)

 

3.31 (0.9)

 

12.57 (2.8)

 

Metastasis

       

 No

52

8.95 (2.7)

0.723

3.11 (1.2)

0.640

12.07 (3.7)

0.682

 Yes

12

9.25 (2.04)

 

4.50 (3.1)

 

11.97 (2.7)